Logo-npj

Brief Communication

1. Association of serum vitamin D level with age in individuals with normal renal function
Hamid Nasri, Mohammad-Reza Ardalan*
J Nephropharmacol. 2012;1(1): 7-9.
Article
PDF
XML
Cited By:
Original

2. Association of serum leptin with serum C-reactive protein in hemodialysis patients
Ebrahim Rastegari, Hamid Nasri*
J Nephropharmacol. 2012;1(2): 19-21.
Article
PDF
XML
Cited By:
Editorial

3. Herbal medicine and diabetic kidney disease
Saeed Mardani, Hamid Nasri, Mahmoud Rafieian-Kopaei*, Shabnam Hajian
J Nephropharmacol. 2013;2(1): 1-2.
Article
PDF
XML
Cited By:
Review

4. Significance of diet in chronic kidney disease
Chaudhary Muhammad Junaid Nazar*
J Nephropharmacol. 2013;2(2): 37-43.
Article
PDF
XML
Cited By:
Mini-Review

5. Diabetic nephropathy; principles of diagnosis and treatment of diabetic kidney disease
Chaudhary Muhammad Junaid Nazar*
J Nephropharmacol. 2014;3(1): 15-20.
Article
PDF
XML
Cited By:
Epidemiology and Prevention

6. Extent of malnutrition in end-stage renal disease patients
Chaudhary Muhammad Junaid Nazar*, John Anderson
J Nephropharmacol. 2014;3(2): 27-28.
Article
PDF
XML
Cited By:
Original

7. TRPC6 gene promoter polymorphisms in steroid resistant nephrotic syndrome children
Kempanahalli Basappa Mahesh Kumar, Senguttuvan Prabha, Elumalai Ramprasad, Lakkakula VKS Bhaskar*, Periasamy Soundararajan
J Nephropharmacol. 2015;4(2): 52-56.
Article
PDF
XML
Cited By:
Commentary

8. Focal segmental glomerulosclerosis and end-stage kidney disease in children
Alaleh Gheissari*
J Nephropharmacol. 2015;4(2): 61-62.
Article
PDF
XML
Cited By:
Editorial

9. Racial disparities in chronic kidney diseases in the United States; a pressing public health challenge with social, behavioral and medical causes
Shervin Assari*
J Nephropharmacol. 2016;5(1): 4-6.
Article
PDF
XML
Cited By:
Review

10. Efficacy of dietary interventions in end-stage renal disease patients; a systematic review
Chaudhary Muhamamd Juniad Nazar*, Micheal Mauton Bojerenu, Muhammad Safdar, Armughan Ahmed, Muhammad Hammad Akhtar, Tiffany Billmeier Kindratt
J Nephropharmacol. 2016;5(1): 28-40.
Article
PDF
XML
Cited By:
Review

11. Diabetic kidney disease: world wide difference of prevalence and risk factors
Osama Gheith*, Nashwa Farouk, Narayanan Nampoory, Medhat A Halim, Torki Al-Otaibi
J Nephropharmacol. 2016;5(1): 49-56.
Article
PDF
XML
Cited By:
Epidemiology and Prevention

12. Diabetes services and care provision
Nadia Kareem, Chaudhary Muhamamd Juniad Nazar*, Syed Nayer Mahmud, Armughan Ahmed, Muhammad Hammad Akhtar
J Nephropharmacol. 2017;6(1): 17-18.
PMCID: PMC5295652     PMID: 28197524    
Article
PDF
XML
Cited By:
1
Original

13. Evaluation of the management of anemia in hemodialysis patients in Lebanon
Marwan Akel*, Kholoud Shamas, Fouad Sakr, Mariam Dabbous, Jihan Safwan, Michelle Cherfan, Mohamad Iskandarani
J Nephropharmacol. 2017;6(2): 68-73. doi: 10.15171/npj.2017.07
Article
PDF
XML
Cited By:
2
Original

14. Albuminuria in patients with young onset type 2 diabetes
Yassamine Bentata*, Redouane Abouqal
J Nephropharmacol. 2017;6(2): 110-113. doi: 10.15171/npj.2017.14
Article
PDF
XML
Cited By:
0
Case Report

15. Pneumocystis pneumonia in a patient with lupus nephritis
Zain Majid*, Afshan Hussain, Hafsa Jawaid, Shoaib Ahmed, Saima Ahmed, Mohammad Mubarak
J Nephropharmacol. 2018;7(1): 40-42. doi: 10.15171/npj.2018.09
Article
PDF
XML
Cited By:
1
Case Report

16. Transient asymptomatic hepatitis B surface antigenemia following recombinant Recombivax B hepatitis B vaccine in a 42-year-old ESRD patient on maintenance hemodialysis
Macaulay Amechi Chukwukadibia Onuigbo*, Catherine Kress, Carol Webb, Nneoma Agbasi
J Nephropharmacol. 2018;7(1): 43-45. doi: 10.15171/npj.2018.10
Article
PDF
XML
Cited By:
0
Original

17. Gabapentin for treatment of restless legs syndrome among hemodialysis patients; a pilot study
Seyed Majid Mousavi Movahed, Gholamreza Alizadeh Attar, Fatemeh Hayati, Shahla Ahmadi Halili, Leila Sabetnia, Seyed Seifollah Beladi Mousavi*
J Nephropharmacol. 2018;7(2): 104-109. doi: 10.15171/npj.2018.22
Article
PDF
XML
Cited By:
0
Original

18. Factors influencing the improvement of self-management behavior in hemodialysis patients 
Mohamad Jebraeily*, Khadijeh Makhdoomi
J Nephropharmacol. 2018;7(2): 110-113. doi: 10.15171/npj.2018.23
Article
PDF
XML
Cited By:
1
Original

19. Evaluation and comparison of quality of life and its related factors in pre-dialysis and hemodialysis patients 
Mohammad Reza Tamadon*, Sajad Hasani, Ensieh Farhidzadeh, Majid Mirmohammadkhani
J Nephropharmacol. 2018;7(2): 114-121. doi: 10.15171/npj.2018.24
Article
PDF
XML
Cited By:
0
Original

20. Effect of intravenous vitamin C supplementation on the quality of sleep, itching and restless leg syndrome in patients undergoing hemodialysis; A double-blind randomized clinical trial
Shahdak Dadashpour, Minoo Sadat Hajmiri*, Daem Roshani
J Nephropharmacol. 2018;7(2): 131-136. doi: 10.15171/npj.2018.27
Article
PDF
XML
Cited By:
5
Original

21. The effect of coenzyme Q10 on cognitive status in chronic hemodialysis patients; a double-blind, randomized, clinical trial
Mohammad Reza Tamadon*, Majid Mirmohammadkhani, Shahb Rafaati
J Nephropharmacol. 2018;7(2): 149-155. doi: 10.15171/npj.2018.30
Article
PDF
XML
Cited By:
0
Mini-Review

22. Lupus nephritis in males; updates to current knowledge  
Faizan Shaukat, Liliya Russinova, Bagzhan Seizhanova, Assel Rakhmetova*
J Nephropharmacol. 2019;8(1): e09. doi: 10.15171/npj.2019.09
Article
PDF
XML
Cited By:
2
Original

23. Caregiver burden among family caregivers of older patients receiving hemodialysis and its relevant factors
Mojtaba Senmar, Hossein Rafiei*, Fateme Yousefi, Ali Razaghpoor, Mohammad Bokharaei
J Nephropharmacol. 2019;8(1): e12. doi: 10.15171/npj.2019.12
Article
PDF
XML
Cited By:
7
Review

24. Association of fetuin-A with kidney disease; a review on current concepts and new data
Marziyeh Akbari ORCID, Hashem Nayeri* ORCID, Hamid Nasri
J Nephropharmacol. 2019;8(2): e14. doi: 10.15171/npj.2019.14
Article
PDF
XML
Cited By:
3
Original

25. Development of a web-based information system for monitoring of hemodialysis adequacy 
Mohamad Jebraeily ORCID, Reza Safdari ORCID, Bahlol Rahimi ORCID, Khadijeh Makhdoomi ORCID, Marjan Ghazisaeedi* ORCID
J Nephropharmacol. 2019;8(2): e19. doi: 10.15171/npj.2019.19
Article
PDF
XML
Cited By:
0
Original

26. Statistical significance of prognostic factors on the progression of chronic kidney disease through simulation study
Alka Sabharwal, Gurprit Grover, Shrawan Kumar*
J Nephropharmacol. 2019;8(2): e20. doi: 10.15171/npj.2019.20
Article
PDF
XML
Cited By:
0
Original

27. A study on variants of focal segmental glomerulosclerosis and their relationship with various biochemical and demographic parameters in kidney biopsies; a single center study 
Fahimeh Fatehi, Seyed Mohsen Hosaini ORCID, Hamid Nasri* ORCID
J Nephropharmacol. 2019;8(2): e24. doi: 10.15171/npj.2019.24
Article
PDF
XML
Cited By:
1
Original

28. Catheter related blood stream infections; the incidence and risk factors in Iranian hemodialysis patients 
Amirhesam Alirezaei* ORCID, Nilofar Massoudi, Elham Zare, Yasser Nouri
J Nephropharmacol. 2019;8(2): e17. doi: 10.15171/npj.2019.17
Article
PDF
XML
Cited By:
1
Epidemiology and Prevention

29. Extra-nasal methicillin-resistant Staphylococcus aureus colonization and maintenance hemodialysis patients
Helmut Schiffl* ORCID
J Nephropharmacol. 2019;8(2): e28. doi: 10.15171/npj.2019.28
Article
PDF
XML
Cited By:
0
Original

30. Knowledge and practices about hemodialysis among dialysis technicians in western part of India
Manish R Balwani* ORCID, Jigar Shrimali ORCID, Amit Pasari ORCID, Jay Shah ORCID, Vivek Kute ORCID
J Nephropharmacol. 2020;9(1): e04. doi: 10.15171/npj.2020.04
Scopus ID: 85084859403    
Article
PDF
XML
Cited By:
0
0
Original

31. Hazardous effect of the maintenance dose of iron sucrose versus iron dextran on oxidative burst activity of neutrophils in patients on regular hemodialysis; a pilot study
Iman Ibrahim Sarhan, Maha Abdelmoneim Behairy*, Hoda Mohamed El Sayed, Doaa Mohamed Abdelaziz
J Nephropharmacol. 2020;9(1): e03. doi: 10.15171/npj.2020.03
Scopus ID: 85084807369    
Article
PDF
XML
Cited By:
0
0
Brief Report

32. Dialysis dose in end-stage renal disease patients undergoing regular hemodialysis at Ibn-Sena and AlNao hospitals in Sudan
Essamaddin A Ibrahim* ORCID
J Nephropharmacol. 2020;9(1): e10. doi: 10.15171/npj.2020.10
Scopus ID: 85084829228    
Article
PDF
XML
Cited By:
1
0
Original

33. Investigation of factors related to N-terminal pro-B type natriuretic peptide levels in hemodialysis patients; a single center study
Farbod Bonakdar, Pegah Noorshargh ORCID, Parin Hedayati, Hamid Nasri* ORCID
J Nephropharmacol. 2020;9(1): e05. doi: 10.15171/npj.2020.05
Scopus ID: 85084792620    
Article
PDF
XML
Cited By:
0
0
Original

34. Morphologic lesions of membranous nephropathy in association with various demographic and laboratory parameters of patients; a single center study

Sara Zamani, Hamid Nasri* ORCID
J Nephropharmacol. 2020;9(1): e09. doi: 10.15171/npj.2020.09
Scopus ID: 85084821061    
Article
PDF
XML
Cited By:
0
0
Review

35. Darbepoetin in chronic kidney disease and dialysis patients; an updated review of outcomes
Tarun Kumar Jeloka* ORCID, Datta Jayanta, Suresh Babu Vallamkonda, Sujeet Narayan Charugulla, Gupta Namita
J Nephropharmacol. 2020;9(2): e14. doi: 10.34172/npj.2020.14
Scopus ID: 85086044411    
Article
PDF
XML
Cited By:
0
0
Original

36. Lack of association between ACE I/D, NOS3 VNTR polymorphisms and drug toxicity of tacrolimus treated post-renal transplantation patients
Kathulapali Krishna ORCID, Sanjana Satheesh ORCID, Gnanasambandan Ramanathan ORCID, Solomon F. D. Paul ORCID, Jayakumar Matcha ORCID, Ramprasad Elumalai* ORCID
J Nephropharmacol. 2020;9(2): e19. doi: 10.34172/npj.2020.19
Scopus ID: 85085948416    
Article
PDF
XML
Cited By:
1
1
Mini Review

37. Strive for kidney health for everyone during COVID-19; the possible theme for the world kidney day 2021
Elahe Aleebrahim-Dehkordi ORCID, Elaheh Mazaheri ORCID, Bijan Roshan ORCID, Bhaskar VKS Lakkakula ORCID, Ali Hasanpour-Dehkordi*, Maryam Khosravian ORCID, Aiyoub Pezeshgi* ORCID
J Nephropharmacol. 2021;10(2): e12. doi: 10.34172/npj.2021.12
Scopus ID: 85111439886    
Article
PDF
XML
Cited By:
2
1

Original

38. Geographical accessibility to the hemodialysis centers in Ardabil, Iran
Maryam Ahmadi ORCID, Mehrnaz Mashoufi* ORCID, Saeed Barzegari ORCID, Sousan Mohammadi Kebar ORCID, Saeed Hoseininia, Babak Hassanlouei ORCID, Hassan Setayeshi Nesaz, Reza Barzegari
J Nephropharmacol. 2022;11(2): e14. doi: 10.34172/npj.2022.14
Scopus ID: 85134184678    
Article
PDF
XML
Cited By:
3
5

Original

39. IL1RN VNTR Polymorphism and kidney damage in sickle cell anemia patients
LVKS Bhaskar* ORCID, Smaranika Pattnaik ORCID
J Nephropharmacol. 2023;12(1): e10437. doi: 10.34172/npj.2022.10437
Scopus ID: 85146856831    
Article
PDF
XML
Cited By:
0
1

Original

40. A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
Saeed Mardani* ORCID, Faranak Sadat Filsouf ORCID
J Nephropharmacol. 2022;11(1): e12. doi: 10.34172/npj.2022.12
Scopus ID: 85119625471    
Article
PDF
XML
Cited By:
0
0

Original

41. A comparison of magnesium sulfate plus morphine with morphine alone for acute pain reduction in long-bone fractures; a double blind randomized clinical trial
Meisam Moezzi ORCID, Hassan Motamed ORCID, Javad Mozafari ORCID, Majid Fattah ORCID, Ali Delirrooyfard* ORCID
J Nephropharmacol. 2022;11(2): e10455. doi: 10.34172/npj.2022.10455
Scopus ID: 85134157680    
Article
PDF
XML
Cited By:
0
0
Review

42. Ameliorative effects of pirfenidone in chronic kidney disease

Samad Ghodrati ORCID, Yeganeh Ragati Haghi ORCID, Jyoti Baharani ORCID, Akshaya Joseph ORCID, Niloufar Alimohammadi ORCID, Farzad Koosha ORCID, Leila Mostafavi ORCID, Aiyoub Pezeshgi* ORCID
J Nephropharmacol. 2022;11(2): e10458. doi: 10.34172/npj.2022.10458
Scopus ID: 85134050498    
Article
PDF
XML
Cited By:
0
0

Original

43. Evaluating risk factors for catheter-related infections in hemodialysis patients
Sepideh Hajian* ORCID, Moosa Seifzade ORCID
J Nephropharmacol. 2022;11(2): e10489. doi: 10.34172/npj.2022.10489
Article
PDF
XML
Cited By:
0
Meta Analysis

44. Effect of allopurinol on the treatment of chronic kidney disease: a systematic review and meta-analysis
Aiyoub Pezeshgi ORCID, Sattar Jafari, Shabnam Pouladvand ORCID, Negin Parsamanesh ORCID, Samad Ghodrati* ORCID, Hamid Nasri* ORCID
J Nephropharmacol. 2023;12(1): e10566. doi: 10.34172/npj.2022.10566
Scopus ID: 85146817118    
Article
PDF
XML
Cited By:
0
0
Clinical Trial

45. The effect of adding ivermectin to the standard COVID-19 treatment in intubated patients
Reza Baghbanian ORCID, Mohsen Savaie* ORCID, Farhad Soltani ORCID, Mahbobeh Rashidi ORCID, Mehrdad Dargahi MalAmir ORCID, Fereshteh Amiri ORCID, Nima Bakhtiari ORCID
J Nephropharmacol. 2023;12(2): e10589. doi: 10.34172/npj.2023.10589
Scopus ID: 85162132129    
Article
PDF
XML
Cited By:
0
0
Original

46. Demographic and clinical features of patients suffering acute intoxication with an emphasis on cardiovascular complications; an observational case series
Pantea Ramezannezhad ORCID, Elham Raeisi ORCID, Ayat Roostami-far, Arsalan Khaledi-far* ORCID
J Nephropharmacol. 2023;12(2): e10597. doi: 10.34172/npj.2023.10597
Scopus ID: 85161973194    
Article
PDF
XML
Cited By:
0
0
Mini-Review

47. Targeted-release budesonide in immunoglobulin A nephropathy; a mini-review
Shiva Toumaj ORCID, Shahrzad Alimohammadi ORCID, Maryam Ghasemi ORCID, Shokouh Shayanpour* ORCID
J Nephropharmacol. 2023;12(2): e10605. doi: 10.34172/npj.2023.10605
Scopus ID: 85162004368    
Article
PDF
XML
Cited By:
0
0
News and Views

48. Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy
Samaneh Zandifar ORCID, Shokouh Shayanpour* ORCID
J Nephropharmacol. 2023;12(2): e10606. doi: 10.34172/npj.2023.10606
Scopus ID: 85161967933    
Article
PDF
XML
Cited By:
0
0
Original

49. Evaluation of risk factors affecting the lifespan and efficiency of dialysis accesses installed in dialysis patients referees to Ahvaz therapeutic centers in a two-year cohort study
Afshin Bighamian ORCID, Iraj Nazari* ORCID, Seyed Masood Mousavi ORCID, Hossain Minaee ORCID
J Nephropharmacol. 2024;13(1): e10639. doi: 10.34172/npj.2023.10639
Article
PDF
XML
Cited By:
0
Meta Analysis

50. The association between metformin administration and non-Hodgkin lymphoma; a systematic review and meta-analysis of cohort and case-control studies
Elnaz Ataei ORCID, Razieh Bagheri Shahzadeh Aliakbari ORCID, Navid Asgari ORCID, Nasim Zaman Samghabadi ORCID, Sina Salati ORCID, Sara Abbasian ORCID, Mohammad Akbari ORCID, Farshad Gharebakhshi ORCID, Anna Ghorbani Doshantapeh* ORCID
J Nephropharmacol. 2024;13(1): e11651. doi: 10.34172/npj.2023.11651
Article
PDF
XML
Cited By:
0
Original

51. Determining the alteration of ghrelin and some biochemical parameters in end-stage kidney disease patients on hemodialysis
Khalid Shaalan Sahab ORCID, Mohammed Asaad Mahdi* ORCID, Ammar M. AL-Azzawi ORCID
J Nephropharmacol. 2025;14(1): e11677. doi: 10.34172/npj.2025.11677
Article
PDF
XML
Cited By:
Meta Analysis

52. The relationship between metformin administration and age-related macular degeneration; a systematic review and meta-analysis of observational studies
Abdulateef Abdulkadhium mashaf* ORCID, Mohammed Abdul-Mounther Othman ORCID, Omer Mansib Kassid ORCID, Hakim S. Sultan Aljibori, Abdul Amir H kadhum ORCID, Ahmed Ali Mohammed ORCID, Raed Muslim Mhaibes ORCID
J Nephropharmacol. 2024;13(2): e12690. doi: 10.34172/npj.2024.12690
Article
PDF
XML
Cited By:
0
Review

53. Comparative histological and clinical differences between children and adults in IgA nephropathy
Samaneh Zandifar ORCID, Azadeh Khayyat ORCID, Arefeh Zahmatkesh* ORCID, Mohammad Ali Esmaeil pour ORCID
J Nephropharmacol. 2024;13(2): e12705. doi: 10.34172/npj.2024.12705
Article
PDF
XML
Cited By:
0
Review

54. The efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on renoprotection in lupus nephritis: a comprehensive review
Shankar Prasad Nagaraju ORCID, Shilna Muttickal Swaminathan ORCID, Priya Rani ORCID, Indu Ramachandra Rao ORCID, Ravindra Prabhu Attur ORCID, Dharshan Rangaswamy ORCID, Srinivas Vinayak Shenoy ORCID, Ankur Gupta ORCID, Mohan V Bhojaraja* ORCID
J Nephropharmacol. 2025;14(1): e12724. doi: 10.34172/npj.2025.12724
Article
PDF
XML
Cited By:
Clinical Trial

55. The effects of oral L-carnitine supplementation on echocardiographic parameters in hemodialysis patients with pulmonary hypertension; a double-blind clinical trial investigation
Afiyeh Mirzaali ORCID, Leila Mahmoodnia ORCID, Marziyeh Nasiri ORCID, Hadi Raeisi Shahraki ORCID, Zahra Habibi* ORCID
J Nephropharmacol. 2025;14(1): e12739. doi: 10.34172/npj.2025.12739
Article
PDF
XML
Cited By: